Mira Pharmaceuticals Inc (NASDAQ: MIRA) is 100.00% higher on its value in year-to-date trading and has touched a low of $0.51 and a high of $7.98 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MIRA stock was last observed hovering at around $2.30 in the last trading session, with the day’s loss setting it -0.2%.
Currently trading at $2.10, the stock is 46.28% and 102.43% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.0 million and changing -8.50% at the moment leaves the stock 54.24% off its SMA200. MIRA registered a loss of 123.55% in past 6-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 218.66% gain in the last 1 month and extending the period to 3 months gives it a 147.09%, and is -11.02% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 28.33% over the week and 37.62% over the month.
Mira Pharmaceuticals Inc (MIRA) has around 3 employees, a market worth around $31.04M and $0.00M in sales. Distance from 52-week low is 311.76% and -73.68% from its 52-week high. The company has generated returns on investments over the last 12 months (-391.51%).
The EPS is expected to grow by 19.53% this year
The shares outstanding are 14.78M, and float is at 9.75M with Short Float at 0.17%.
Mira Pharmaceuticals Inc (MIRA) Insider Activity
The most recent transaction is an insider purchase by Aminov Erez, the company’s Chief Executive Officer. SEC filings show that Aminov Erez bought 8,700 shares of the company’s common stock on May 21 ’24 at a price of $0.94 per share for a total of $8176.0. Following the purchase, the insider now owns 0.38 million shares.
Mira Pharmaceuticals Inc disclosed in a document filed with the SEC on Dec 11 ’23 that McNulty Brian Patrick (10% Owner) sold a total of 46,005 shares of the company’s common stock. The trade occurred on Dec 11 ’23 and was made at $1.55 per share for $71496.0. Following the transaction, the insider now directly holds 0.66 million shares of the MIRA stock.
Still, SEC filings show that on Dec 08 ’23, McNulty Brian Patrick (10% Owner) disposed off 19,053 shares at an average price of $1.61 for $30633.0. The insider now directly holds 683,002 shares of Mira Pharmaceuticals Inc (MIRA).
